Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation
Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people.Design Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was...
Saved in:
| Published in | BMJ Vol. 342; no. apr01 1; p. d682 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
British Medical Journal Publishing Group
01.04.2011
BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people.Design Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress.Participants Adolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care.Setting Eight child and adolescent mental health services in the northwest UK.Interventions Manual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres.Main outcome measures Primary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded.Results 183 adolescents were allocated to each arm (total n=366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P=0.95) at 6 months and 0.88 (0.59 to 1.33, P=0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to1.20, P=0.29) at 6 months and 0.94 (0.63 to 1.40, P=0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21 781) than for routine care (£15 372) but the difference was not significant (95% CI −1416 to 10782, P=0.132).Conclusions The addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations.Trial registration ISRCTN 20496110 |
|---|---|
| AbstractList | OBJECTIVETo examine the effectiveness and cost-effectiveness of group therapy for self harm in young people.DESIGNTwo arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress.PARTICIPANTSAdolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care. Setting Eight child and adolescent mental health services in the northwest UK.INTERVENTIONSManual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres.MAIN OUTCOME MEASURESPrimary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded.RESULTS183 adolescents were allocated to each arm (total n = 366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P = 0.95) at 6 months and 0.88 (0.59 to 1.33, P = 0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to 1.20, P = 0.29) at 6 months and 0.94 (0.63 to 1.40, P = 0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21,781) than for routine care (£15,372) but the difference was not significant (95% CI -1416 to 10782, P = 0.132).CONCLUSIONSThe addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations. Trial registration ISRCTN 20496110. To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress. Adolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care. Setting Eight child and adolescent mental health services in the northwest UK. Manual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres. Primary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded. 183 adolescents were allocated to each arm (total n = 366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P = 0.95) at 6 months and 0.88 (0.59 to 1.33, P = 0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to 1.20, P = 0.29) at 6 months and 0.94 (0.63 to 1.40, P = 0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21,781) than for routine care (£15,372) but the difference was not significant (95% CI -1416 to 10782, P = 0.132). The addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations. Trial registration ISRCTN 20496110. Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Design Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress. Participants Adolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care. Setting Eight child and adolescent mental health services in the northwest UK. Interventions Manual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres. Main outcome measures Primary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded. Results 183 adolescents were allocated to each arm (total n=366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P=0.95) at 6 months and 0.88 (0.59 to 1.33, P=0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to1.20, P=0.29) at 6 months and 0.94 (0.63 to 1.40, P=0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21 781) than for routine care (£15 372) but the difference was not significant (95% CI -1416 to 10782, P=0.132). Conclusions The addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations. Trial registration ISRCTN 20496110 Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Design Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress. Participants Adolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care. Setting Eight child and adolescent mental health services in the northwest UK. Interventions Manual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres. Main outcome measures Primary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded. Results 183 adolescents were allocated to each arm (total n=366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P=0.95) at 6 months and 0.88 (0.59 to 1.33, P=0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to1.20, P=0.29) at 6 months and 0.94 (0.63 to 1.40, P=0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21 781) than for routine care (£15 372) but the difference was not significant (95% CI −1416 to 10782, P=0.132). Conclusions The addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations. Trial registration ISRCTN 20496110 Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Design Two arm, single (assessor) blinded parallel randomised allocation trial of a group therapy intervention in addition to routine care, compared with routine care alone. Randomisation was by minimisation controlling for baseline frequency of self harm, presence of conduct disorder, depressive disorder, and severity of psychosocial stress. Participants Adolescents aged 12-17 years with at least two past episodes of self harm within the previous 12 months. Exclusion criteria were: not speaking English, low weight anorexia nervosa, acute psychosis, substantial learning difficulties (defined by need for specialist school), current containment in secure care. Setting Eight child and adolescent mental health services in the northwest UK. Interventions Manual based developmental group therapy programme specifically designed for adolescents who harm themselves, with an acute phase over six weekly sessions followed by a booster phase of weekly groups as long as needed. Details of routine care were gathered from participating centres. Main outcome measures Primary outcome was frequency of subsequent repeated episodes of self harm. Secondary outcomes were severity of subsequent self harm, mood disorder, suicidal ideation, and global functioning. Total costs of health, social care, education, and criminal justice sector services, plus family related costs and productivity losses, were recorded. Results 183 adolescents were allocated to each arm (total n=366). Loss to follow-up was low (<4%). On all outcomes the trial cohort as a whole showed significant improvement from baseline to follow-up. On the primary outcome of frequency of self harm, proportional odds ratio of group therapy versus routine care adjusting for relevant baseline variables was 0.99 (95% confidence interval 0.68 to 1.44, P=0.95) at 6 months and 0.88 (0.59 to 1.33, P=0.52) at 1 year. For severity of subsequent self harm the equivalent odds ratios were 0.81 (0.54 to1.20, P=0.29) at 6 months and 0.94 (0.63 to 1.40, P=0.75) at 1 year. Total 1 year costs were higher in the group therapy arm (£21 781) than for routine care (£15 372) but the difference was not significant (95% CI −1416 to 10782, P=0.132). Conclusions The addition of this targeted group therapy programme did not improve self harm outcomes for adolescents who repeatedly self harmed, nor was there evidence of cost effectiveness. The outcomes to end point for the cohort as a whole were better than current clinical expectations. Trial registration ISRCTN 20496110 |
| Author | Trainor, G Byford, S Wood, A J Woodham, A Barrett, B Green, J M Roberts, C Ayodeji, E Kerfoot, M J Rothwell, J Harrington, R |
| Author_xml | – sequence: 1 givenname: J M surname: Green fullname: Green, J M email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 2 givenname: A J surname: Wood fullname: Wood, A J email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 3 givenname: M J surname: Kerfoot fullname: Kerfoot, M J email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 4 givenname: G surname: Trainor fullname: Trainor, G email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 5 givenname: C surname: Roberts fullname: Roberts, C email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 6 givenname: J surname: Rothwell fullname: Rothwell, J email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 7 givenname: A surname: Woodham fullname: Woodham, A email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 8 givenname: E surname: Ayodeji fullname: Ayodeji, E email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 9 givenname: B surname: Barrett fullname: Barrett, B email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 10 givenname: S surname: Byford fullname: Byford, S email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester – sequence: 11 givenname: R surname: Harrington fullname: Harrington, R email: jonathan.green@manchester.ac.uk organization: Manchester Biomedical Research Centre and Academic Health Sciences Centre, Manchester |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21459975$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kVuLFDEQhYOsuOO64C-QBh_0pdek07n5IMioq7CMCN7wJaSTGqdn0502Sa_uvzfDrOMFfEqo-lJ1Ts5ddDSGERC6T_AZIZQ_6YbtmeOyuYUWpOWyZpLSI7TAiqlaEiqP0WlKW4xxQ4VUnN1Bxw1pmVKCLdDleQzzVOUNRDNdV-sQK-OCh2RhzKn63udNFWECk8FVCfy62pg4PK2iGV0Y-lSqNow5Bu_LNcfe-P0jKOUC2AqujJ9N7sN4D91eG5_g9OY8QR9evXy_fF1fvD1_s3x-UXctZ7lunOjYGjtQqiGOu07QzraWc6eY61rScUq6FjdMNWBbxjEDaQSn3DatFZbQE_RsP3eauwHczkk0Xk-xH0y81sH0-u_O2G_013ClKeaKy7YMeHQzIIZvM6Ssi1ML3psRwpy05JiUr8S4kA__IbdhjmNxp4kiWAhZZBbq8Z6yMaQUYX3QQrDeZahLhnqXYUEf_Kn9AP5KrAD1HuhThh-HvomXmgsqmF59XOqVWn159_nTC81-K9yt-O_an99ptkw |
| CitedBy_id | crossref_primary_10_1111_jcap_12035 crossref_primary_10_1136_archdischild_2013_304448 crossref_primary_10_1002_14651858_CD013667_pub2 crossref_primary_10_1080_15374416_2014_945211 crossref_primary_10_1007_s10560_017_0505_5 crossref_primary_10_1001_jamanetworkopen_2021_6614 crossref_primary_10_1002_14651858_CD012955_pub2 crossref_primary_10_1001_jama_2022_16310 crossref_primary_10_1186_1753_2000_6_14 crossref_primary_10_1002_14651858_CD013768 crossref_primary_10_1016_j_psychres_2024_116017 crossref_primary_10_3310_hsdr06030 crossref_primary_10_1016_j_jaac_2014_07_003 crossref_primary_10_1136_eb_2014_101840 crossref_primary_10_1016_j_jaac_2012_09_018 crossref_primary_10_1007_s00787_012_0269_6 crossref_primary_10_1080_08927936_2019_1621539 crossref_primary_10_1080_13811118_2019_1592043 crossref_primary_10_1111_camh_12661 crossref_primary_10_1111_inm_12093 crossref_primary_10_3310_hta22120 crossref_primary_10_1176_appi_focus_23021004 crossref_primary_10_1186_s40479_020_00123_9 crossref_primary_10_3389_fpsyt_2018_00583 crossref_primary_10_1001_jamapsychiatry_2018_1079 crossref_primary_10_3389_fpsyg_2019_00104 crossref_primary_10_1192_apt_22_5_287 crossref_primary_10_1146_annurev_clinpsy_032813_153742 crossref_primary_10_1080_15374416_2014_940624 crossref_primary_10_1186_1753_2000_8_9 crossref_primary_10_1016_S2215_0366_18_30058_0 crossref_primary_10_1080_14789949_2018_1508488 crossref_primary_10_1177_1757913914552583 crossref_primary_10_1016_j_eclinm_2018_10_004 crossref_primary_10_1007_s00278_013_1027_z crossref_primary_10_1016_j_jaac_2013_09_009 crossref_primary_10_1176_appi_ajp_2020_20060864 crossref_primary_10_1192_bjp_bp_113_138941 crossref_primary_10_1080_15374416_2019_1591281 crossref_primary_10_1186_1471_244X_13_328 crossref_primary_10_1016_j_jaac_2014_10_009 crossref_primary_10_1027_0227_5910_a000476 crossref_primary_10_1007_s00103_021_03466_y crossref_primary_10_1007_s40501_021_00239_x crossref_primary_10_1002_14651858_CD012013 crossref_primary_10_1136_ebmental_2018_300056 crossref_primary_10_1007_s00787_015_0783_4 crossref_primary_10_1016_S2215_0366_16_30030_X crossref_primary_10_1186_s12888_017_1527_4 crossref_primary_10_1097_NMD_0000000000001476 crossref_primary_10_1186_s12874_020_01117_5 crossref_primary_10_1016_j_vhri_2021_08_005 crossref_primary_10_5694_mja17_00972 crossref_primary_10_1016_S0140_6736_12_60322_5 crossref_primary_10_1192_apt_bp_112_011049 crossref_primary_10_1016_j_vhri_2021_02_006 crossref_primary_10_2196_16963 crossref_primary_10_1016_j_eclinm_2019_100246 crossref_primary_10_1007_s40501_014_0008_3 crossref_primary_10_1111_j_1943_278X_2012_0087_x crossref_primary_10_1111_sltb_12416 crossref_primary_10_3310_hsdr02180 crossref_primary_10_1016_j_jad_2021_12_094 crossref_primary_10_1136_bmj_2022_070630 crossref_primary_10_11622_smedj_2013170 crossref_primary_10_1177_0004867416661039 crossref_primary_10_1016_j_jaac_2012_09_004 crossref_primary_10_1177_070674371405900604 |
| ContentType | Journal Article |
| Copyright | Green et al 2011 Copyright: 2011 © Green et al 2011 Green et al 2011 2011 Green et al |
| Copyright_xml | – notice: Green et al 2011 – notice: Copyright: 2011 © Green et al 2011 – notice: Green et al 2011 2011 Green et al |
| DBID | 9YT ACMMV BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88I 8AF 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA ASE AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH HCIFZ K6X K9. KB0 LK8 M2O M2P M7P MBDVC NAPCQ PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/bmj.d682 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Source (ProQuest) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central British Nursing Index ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Research Library ProQuest Science Journals Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-5833 1756-1833 |
| EndPage | d682 |
| ExternalDocumentID | 10_1136_bmj_d682 21459975 ark_67375_NVC_N9NZQXWD_5 ttp://bmj.com/content/342/bmj.d682.full |
| Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | .GJ 0R~ 23N 2WC 39C 3O- 4.4 40O 53G 5GY 7RV 7X7 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8G5 9YT AACGO AAKAS AANCE AAWJN ABBHK ABIVO ABJNI ABPLY ABTLG ABUWG ABVAJ ABXSQ ACGFS ACGOD ACMFJ ACMMV ACPRK ADACV ADBBV ADCEG ADULT ADZCM AEUPB AEXZC AFKRA AGFXO AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AQVQM ASPBG AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BTHHO C45 CAG CCPQU COF CS3 DCCCD DIK DOOOF DWQXO EBS EJD EX3 F5P FEDTE FYUFA GNUQQ GUQSH H13 HAJ HCIFZ HMCUK HQ3 HTVGU HVGLF HZ~ IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST L7B LK8 M2O M2P M7P NAPCQ NTWIH NXWIF O9- OVD PQQKQ PROAC R53 RHF RHI RMJ RV8 SA0 TEORI UHU UKHRP VVN WHG WOQ WOW YFH YQY BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7XB 8FK ASE FPQ K6X K9. MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-b465t-2d7b5f0de9921d6db73bc4c66d95db41b631b402592ec45605e8a7636c24c7c13 |
| IEDL.DBID | 9YT |
| ISSN | 0959-8138 |
| IngestDate | Tue Sep 17 21:14:15 EDT 2024 Fri Oct 25 06:56:17 EDT 2024 Thu Oct 10 19:30:28 EDT 2024 Fri Aug 23 02:11:48 EDT 2024 Sat Sep 28 08:29:58 EDT 2024 Wed Oct 30 09:30:18 EDT 2024 Wed Aug 21 03:28:53 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | apr01 1 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b465t-2d7b5f0de9921d6db73bc4c66d95db41b631b402592ec45605e8a7636c24c7c13 |
| Notes | ArticleID:grej764688 href:bmj-342-bmj-d682.pdf istex:929B70226BF83D1BC973EAEC11D2F577A79D5FE8 ark:/67375/NVC-N9NZQXWD-5 local:bmj;342/apr01_1/d682 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://dx.doi.org/10.1136/bmj.d682 |
| PMID | 21459975 |
| PQID | 1910778259 |
| PQPubID | 2043523 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3069684 proquest_miscellaneous_860178900 proquest_journals_1910778259 crossref_primary_10_1136_bmj_d682 pubmed_primary_21459975 istex_primary_ark_67375_NVC_N9NZQXWD_5 bmj_primary_10_1136_bmj_d682 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-04-01 |
| PublicationDateYYYYMMDD | 2011-04-01 |
| PublicationDate_xml | – month: 04 year: 2011 text: 2011-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMJ |
| PublicationTitleAlternate | BMJ |
| PublicationYear | 2011 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group Ltd |
| References | 1995; 91 1993; 306 2000; 212 2005; 331 2000; 23 1995; 34 1999; 4 2007; 191 1998; 111 1998; 21 1996; 37 1996; 10 2001; 40 2003; 32 2009; 48 1995; 5 2003; 33 1998; 37 1991; 48 2006; 45 2005; 187 1997; 54 2000; 34 1993; 32 2006; 47 1999; 175 1999; 56 1999; 174 2010; 197 2000; 320 2006; 188 2009; 18 21764883 - Evid Based Ment Health. 2011 Aug;14(3):84 |
| References_xml | – volume: 174 start-page: 56 year: 1999 publication-title: Br J Psychiatry – volume: 47 start-page: 927 year: 2006 publication-title: J Child Adolesc Psychol Psychiatry – volume: 175 start-page: 271 year: 1999 publication-title: Br J Psychiatry – volume: 48 start-page: 662 year: 2009 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 23 start-page: 47 year: 2000 publication-title: J Adolesc – volume: 34 start-page: 1308 year: 1995 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 4 start-page: CD001764 year: 1999 publication-title: Cochrane Database Syst Rev – volume: 37 start-page: 512 year: 1998 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 5 start-page: 237 year: 1995 publication-title: Int J Meth Psychiatr Res – volume: 191 start-page: 436 year: 2007 publication-title: Br J Psychiatry – volume: 320 start-page: 1197 year: 2000 publication-title: BMJ – volume: 111 start-page: 44 year: 1998 publication-title: N Z Med J – volume: 187 start-page: 106 year: 2005 publication-title: Br J Psychiatry – volume: 306 start-page: 1641 year: 1993 publication-title: BMJ – volume: 197 start-page: 5 year: 2010 publication-title: Br J Psychiatry – volume: 188 start-page: 547 year: 2006 publication-title: Br J Psychiatry – volume: 32 start-page: 106 year: 1993 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 48 start-page: 1060 year: 1991 publication-title: Arch Gen Psychiatry – volume: 33 start-page: 977 year: 2003 publication-title: Psychol Med – volume: 188 start-page: 541 year: 2006 publication-title: Br J Psychiatry – volume: 34 start-page: 437 year: 2000 publication-title: Aust N Z J Psychiatry – volume: 45 start-page: 337 year: 2006 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 212 start-page: 268 year: 2000 publication-title: Klin Padiatr – volume: 32 start-page: 284 year: 2003 publication-title: J Clin Child Adolesc Psychol – volume: 37 start-page: 737 year: 1996 publication-title: J Child Psychol Psychiatry – volume: 191 start-page: 521 year: 2007 publication-title: Br J Psychiatry – volume: 34 start-page: 420 year: 2000 publication-title: Aust N Z J Psychiatry – volume: 174 start-page: 413 year: 1999 publication-title: Br J Psychiatry – volume: 56 start-page: 617 year: 1999 publication-title: Arch Gen Psychiatry – volume: 91 start-page: 265 year: 1995 publication-title: Acta Psychiatr Scand – volume: 10 start-page: 236 year: 1996 publication-title: Children Soc – volume: 21 start-page: 209 year: 1998 publication-title: J Adolesc – volume: 18 start-page: 297 year: 2009 publication-title: J Mental Health – volume: 40 start-page: 1246 year: 2001 publication-title: J Am Acad Child Adolesc Psychiatry – volume: 331 start-page: 805 year: 2005 publication-title: BMJ – volume: 54 start-page: 877 year: 1997 publication-title: Arch Gen Psychiatry |
| SSID | ssj0002378965 ssj0002378964 |
| Score | 2.1705852 |
| Snippet | Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people.Design Two arm, single (assessor) blinded parallel... Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Design Two arm, single (assessor) blinded... To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Two arm, single (assessor) blinded parallel randomised... OBJECTIVETo examine the effectiveness and cost-effectiveness of group therapy for self harm in young people.DESIGNTwo arm, single (assessor) blinded parallel... Objective To examine the effectiveness and cost-effectiveness of group therapy for self harm in young people. Design Two arm, single (assessor) blinded... |
| SourceID | pubmedcentral proquest crossref pubmed istex bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | d682 |
| SubjectTerms | Adolescent Adolescents Anorexia Child Child and Adolescent Psychiatry Child and Adolescent Psychiatry (Paedatrics) Cognition & reasoning Comorbidity Conduct Disorder - complications Cost analysis Cost-Benefit Analysis Depressive Disorder - complications Disability Eating Disorders Evidence-based medicine Female Group therapy Health Economics Health Policy Health Service Research Health services Humans Intervention Male Mental depression Mental disorders Mental health Mood Mood Disorders (Including Depression) Psychiatry Psychosis Psychotherapy Psychotherapy, Group - economics Psychotic Disorders (Incl Schizophrenia) Recurrence Self destructive behavior Self-Injurious Behavior - economics Self-Injurious Behavior - psychology Self-Injurious Behavior - therapy Single-Blind Method Social interactions Stress, Psychological - complications Suicides & suicide attempts Teenagers Treatment Outcome |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB7RXQnxgihXlx4yEuItNJftmBcEPVQhNWoRhRUvlh07amnJbne3Evx7ZhJv2kWob5HjHJrx2PONx98AvOF1kmQFGiAu1irKTZ1GSiqJFo8wLpbSpC27_nEpjs7yz2M-DgG3eUirXM6J7UTtJhXFyHcRV-CjiGfUh-l1RFWjaHc1lNBYg2GKSCEewPDTQXnypY-ypJkslOCBdTbJxK799fOdE8S7t4aXK6vRkAT7-3-u5r8Zk3eWoMMn8Dj4juxjp-x1eOCbp_DwOOyOP4PLNpDEuiNVfxi6o-wOYROjkCub-SnOvt6xub-qGfFWv2e4XLkJ6htbQ-b6FV629Ty6h3w4vcxuucGfw9nhwde9oygUU4hsLvgiSp20vI6dVypNqIqUzGyVV0I4xZ3NEyuyxCKY5Cr1FXpVMfeFwclHVGleySrJXsCgmTR-A5hEEJYVxOXHPdm_dcpIY_I6LiobWzOCLRStnnZ0GbqFGZnQ1EaSH8Hrpczv6fO2VUbfwcwuKQVNcl1-29OlKn-cjr_va47fWmpLB-ub69uxMgLW30Y50maIafzkZq4LRKJ0CDgewctOt_23iLxdKYnvlita7zsQJffqnebivKXmRgCmRJG_uv-vNuFRF5qmBKAtGCxmN34bfZuF3QkD-C-kM_vX priority: 102 providerName: ProQuest |
| Title | Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation |
| URI | http://dx.doi.org/10.1136/bmj.d682 https://api.istex.fr/ark:/67375/NVC-N9NZQXWD-5/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/21459975 https://www.proquest.com/docview/1910778259 https://search.proquest.com/docview/860178900 https://pubmed.ncbi.nlm.nih.gov/PMC3069684 |
| Volume | 342 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-NVUK8oPG5slEZhHgLJHH8xdsomyakRoC2UXix7MQRsJFObSfBf89dkmYtmvYUx3Zs6S7n-7J_BnglqiThGgUQlbWJMlelkVFGocSjGxcr5dIGXX-Sy-PT7ONUTLfg5c0Z_ITLt_73rzel1LjMDgiqnITPfDvp4ygpV3qVObx-Fy3EHkW4uO4wZ9cHQ02CxQ1dNCCy_rnJ0Px_v-SaAjragfud5cgOWlY_gK1QP4S7ky43_gjOmzASaw9U_WVojLI1uCZGAVc2D5e49oaSLcJFxQi1-h1DZVXOkNtY2-1bv8Bic5tH-1Hozi6za2Twx3B6dHgyPo66qxQin0mxjNJSeVHFZTAmTegOKcV9kRVSlkaUPku85IlHV1KYNBRoU8UiaIdLjyzSrFBFwp_Adj2rwy4whS4Y14TkJwJJvy-NU85lVawLH3s3hH0krb1swTJs42RwaamOKD-EFyua39LndcOMvoObn9MGNCVsfja2ucm_f55-_WAFzrXilu1kb2HRA8WfDD1fMwTWNyMdKRXi6jC7WliNfigdAY6H8LTlbT8XQbcbo3BstcH1vgMBcm-21D9_NMDc6H4ZqbNnt1NgD-61gWna_rMP28v5VXiOls3Sj-COmqpR84OPYHAwnkzO8Pn-MP_05R89FPfG |
| link.rule.ids | 230,315,783,787,888,12068,21400,27561,27562,27868,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630 |
| linkProvider | BMJ Publishing Group Ltd |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB71IQEXRHkulGIkxC00L9txLwiVVgt0IyG1sOJi2bEjoCW77G4l-u-ZSbxpt6p6s_yIoxmPPTMefwPwhtdJkhUogHhYqyg3dRopqSRKPJpxsZQmbdH1R6UYnuSfx3wcHG7zEFa53BPbjdpNKvKR76JdgUPRnlHvp38jyhpFt6shhcY6bBIOF2UwkGPZ-1jSTBZK8IA5m2Ri1_75_c4JQt1bx-LKWbRJZP13k6J5PV7yygF0-ADuB82RfehYvQVrvnkId0bhbvwRnLZuJNY9qLpgqIyyK3BNjByubOanuPd6x-b-rGaEWr3H8LByE-Q21oa49TMsttk8ukE-vF1ml8jgj-Hk8OB4fxiFVAqRzQVfRKmTltex80qlCeWQkpmt8koIp7izeWJFllg0JblKfYU6Vcx9YXDrEVWaV7JKsiew0Uwa_wyYRBMsKwjJj3uSfuuUkcbkdVxUNrZmANtIWj3twDJ0a2RkQlMdUX4Ar5c0v6XP25YZfQczO6UANMl1-W1fl6r88XX8_aPmONeSWzrI3lxfrpQBsL4Z6UhXIabxk_O5LtAOpSfA8QCedrzt5yLodqUkfluucL3vQIDcqy3Nr58tMDeaX0oU-fPb_-oV3B0ej4700afyywu41zmpKRRoGzYWs3P_ErWchd1pl_J_bGr9Yg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdYK028IL4pDDAS4i00ib9iXhBsq8bHooEYVLxYduwI2EhL20nw33OXuNmK0N4sf8TRnX2-O59_R8hTUWcZK2ADwmGtE27rPNFKK9jxYMalStm8Rdc_LOXBMX87FdMY_7SMYZVrmdgKaj-r0Ec-BrsChoI9o8d1DIs42pu8nP9KMIMU3rTGdBpbZKi4ZOmADF_vl0cfe49LzlShpYgItBmTY_fzx3MvEYNvC4obJ9MQifz7f2rnv9GTF46jyXVyLeqR9FXH-BvkSmhuku3DeFN-i5y0TiXaPa_6Q0E1pRfAmyi6X-kizEESB0-X4bSmiGH9gsLR5WfAe6iNUeynUGxze3SDQnzJTM9xwm-T48n-p92DJCZWSByXYpXkXjlRpz5onWeYUUoxV_FKSq-FdzxzkmUODEuh81CBhpWKUFgQRLLKeaWqjN0hg2bWhHuEKjDIWIG4fiKgLHBeW2Utr9OicqmzI7IDpDXzDjrDtCYHkwbrkPIj8mRN80v6PGuZ0XewixMMR1PClJ93TanLrx-mX_aMgLnW3DJxJy7N-boZEdo3Ax3xYsQ2YXa2NAVYpfggOB2Rux1v-7kQyF1rBd9WG1zvOyA892ZL8_1bC9MNxpiWBb9_-V89Jtuwjs37N-W7B-Rq57HGuKAdMlgtzsJDUHlW7lFcy38BackDDg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Group+therapy+for+adolescents+with+repeated+self+harm%3A+randomised+controlled+trial+with+economic+evaluation&rft.jtitle=BMJ&rft.au=Green%2C+J+M&rft.au=Wood%2C+A+J&rft.au=Kerfoot%2C+M+J&rft.au=Trainor%2C+G&rft.date=2011-04-01&rft.issn=0959-8138&rft.eissn=1468-5833&rft.volume=342&rft_id=info:doi/10.1136%2Fbmj.d682&rft.externalDBID=ttp%3A%2F%2Fbmj.com%2Fcontent%2F342%2Fbmj.d682.full.pdf&rft.externalDocID=ttp%3A%2F%2Fbmj.com%2Fcontent%2F342%2Fbmj.d682.full |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-8138&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-8138&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-8138&client=summon |